Abstract
e15166 Background: Y90 radioembolization has become an increasingly common palliative measure for patients with unresectable metastatic neuroendocrine tumors (NETs) in the liver. The amount by whic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
